Galecto Inc (GLTO)

Currency in USD
3.320
-0.270(-7.52%)
Closed·
After Hours
3.150-0.170(-5.12%)
·
GLTO Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual Post-Market activity
Fair Value
Day's Range
3.1203.460
52 wk Range
2.01015.130
Key Statistics
Prev. Close
3.32
Open
3.46
Day's Range
3.12-3.46
52 wk Range
2.01-15.13
Volume
18.36K
Average Volume (3m)
41.96K
1-Year Change
-76.33%
Book Value / Share
9.34
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GLTO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.000
Upside
+80.72%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Galecto Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Galecto Inc Company Profile

Galecto, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.

Compare GLTO to Peers and Sector

Metrics to compare
GLTO
Peers
Sector
Relationship
P/E Ratio
−0.2x−1.4x−0.5x
PEG Ratio
−0.010.000.00
Price/Book
0.4x2.5x2.6x
Price / LTM Sales
-9.7x3.3x
Upside (Analyst Target)
80.7%301.6%42.4%
Fair Value Upside
Unlock20.3%7.2%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 6.000
(+80.72% Upside)

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-1.92 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

GLTO Income Statement

People Also Watch

16.75
SRPT
+5.81%
0.770
WINT
-5.52%
4.7800
CLRB
+1.49%
0.474
ADIL
-21.78%
0.167
VTAK
-6.70%

FAQ

What Stock Exchange Does Galecto Trade On?

Galecto is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Galecto?

The stock symbol for Galecto is "GLTO."

What Is the Galecto Market Cap?

As of today, Galecto market cap is 4.39M.

What Is Galecto's Earnings Per Share (TTM)?

The Galecto EPS (TTM) is -15.20.

From a Technical Analysis Perspective, Is GLTO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Galecto Stock Split?

Galecto has split 1 times.

How Many Employees Does Galecto Have?

Galecto has 5 employees.

What is the current trading status of Galecto (GLTO)?

As of 31 Jul 2025, Galecto (GLTO) is trading at a price of 3.32, with a previous close of 3.32. The stock has fluctuated within a day range of 3.12 to 3.46, while its 52-week range spans from 2.01 to 15.13.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.